- Home
- / Shanghai Rightongene Biotechnology
Shanghai Rightongene Biotechnology
Stock Price
¥17.8
2024-10-29
Market Capitalization
¥947.9 M
2024-10-29
Revenue
¥170.7 M
FY, 2025
Shanghai Rightongene Biotechnology Summary
Company Summary
- Overview
- Shanghai Rightongene Biotechnology (上海睿昂基因科技股份有限公司) is a company that manufactures and sells diagnostic products. It offers molecular diagnostic kits. The company also provides tumor screening and detection, and antigen testing services.
- Type
- Public
- Status
- Active
- Founded
- 2012
- HQ
- CN | view all locations
- Website
- http://www.rightongene.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Shang Hai Shi HQ
China
Jin Hai Gong Lu, Feng Xian Qu
Shanghai Rightongene Biotechnology Financials
Summary Financials
- Revenue (FY, 2025)
- ¥170.7M
- Gross profit (FY, 2025)
- ¥130.3M
- Net income (FY, 2025)
- (¥60.4M)
- Cash (FY, 2025)
- ¥104.4M
- EBIT (FY, 2025)
- (¥54.1M)
- Enterprise value
- $844.7M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026